University Of Cincinnati
Clinical trials sponsored by University Of Cincinnati, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Cystic fibrosis hormone clues sought in meal study Results expected Sep 2026 (estimated)
- Brain wave tracking may improve care after severe head trauma Results expected Sep 2026 (estimated)
- Brain cancer survivors try VR games to boost memory and mood Results expected Nov 2026 (estimated)
- Can a 3D-Printed jaw model cut surgery time for broken jaws? Results expected Dec 2026 (estimated)
- New lattice radiation aims to shrink bulky tumors and ease pain Results expected Jan 2027 (estimated)
-
Liver cancer immunotherapy study halted early
Disease control Stopped earlyThis study tested two immunotherapy drugs (durvalumab and tremelimumab) in people with liver cancer who were waiting for a liver transplant. The goal was to see if the drugs could safely shrink tumors and control the disease without causing organ rejection. Only 8 people took par…
Phase 2 • Sponsor: University of Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New heart artery measurements could sharpen diagnosis
Diagnosis Stopped earlyThis study tests new methods to measure pressure, blood flow, and blockage size in heart arteries. Researchers want to see if these measurements can better identify which blockages are serious enough to cause heart damage. The study involves people with known or suspected coronar…
Sponsor: University of Cincinnati • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC